Healthcare
Live Price
Offline$8.54
+0.00% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Chimerix, Inc. (CMRX) is a Healthcare stock with a market cap of $801.08M. The stock last traded around $8.54. Baseline metrics include revenue growth of -34.6%, EPS growth of -6.5%, a dividend yield of 0.0%. What stands out right now is revenue -34.6%, EPS -6.5%, free cash flow -8.8% with operating margin -45550.5% and ROIC -79.1%. Valuation already assumes a fairly strong business story at price/sales 3778.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CMRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CMRX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CMRX Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CMRX and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$5.4M
+171.5% YoY
FY Net Income
-$42.1M
+83.5% YoY
Free Cash Flow
-$36.1M
+64.0% YoY
Revenue Growth
-34.6%
EPS Growth
-6.5%
Gross Margin
100.0%
Net Margin
-41692.0%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 212K | 324K | 34M | 2M | 5M |
| Gross Profit | 212K | 324K | 33M | 2M | -31M |
| Operating Income | -97M | -93M | -60M | -173M | -45M |
| EBITDA | -96M | -93M | -60M | -90M | -44M |
| Net Income | -88M | -82M | 172M | -256M | -42M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 31M | 28M | 26M | 15M | 47M |
| Total Assets | 146M | 213M | 279M | 101M | 85M |
| Total Liabilities | 24M | 20M | 22M | 32M | 11M |
| Shareholder Equity | 122M | 193M | 257M | 68M | 73M |
| Total Debt | 458K | 1M | 2M | 16M | 3M |
| Net Debt | -31M | -26M | -24M | 995K | -44M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
36M
+63.9% YoY
Capital Expenditures
58K
+72.0% YoY
Free Cash Flow
36M
+64.0% YoY
Key ratios
Gross Margin
100.0%
Operating Margin
-45550.5%
Net Margin
-41692.0%
ROE
-56.2%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.